All sponsors

Zhejiang Doer Biologics Co., Ltd.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS5
PHASE 3 / 2-32
RECRUITING1
READOUTS ≤12 MONTHS1
Open Zhejiang Doer Biologics Co., Ltd. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
DR10624 Injection
NCT07024212
P2Active, not recruitingMASLD1102026-06-18
DR30206
NCT07056777
P1/2RecruitingGastrointestinal Cancer1862027-04-30 (+12 mo)
DR10624 Injection
NCT07848880
P2Not yet recruitingHypertriglyceridemia3152028-04
DR10624 Injection
NCT07693777
P3Not yet recruitingSevere Hypertriglyceridemia (sHTG); Hypertriglyceridemia4802029-02-14
DR10624 Subcutaneous Injection
NCT07680829
P3Not yet recruitingSevere Hypertriglyceridemia3782030-06